InsiderClue
Insiders · Profile

O'Grady Brendan P.

EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 5 Mar 2018. CIK 0001726533

Company
Date
Role
Action
Shares
Amount
Of holding
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
5 Mar 2021
EVP, North America Commercial
Sold, plan not stated
11,436
$120.58K
43.5%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
4 Mar 2021
EVP, North America Commercial
Sold, plan not stated
8,172
$86.51K
35.5%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
3 Mar 2021
EVP, North America Commercial
Sold, plan not stated
463
$5.03K
2.9%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
2 Mar 2021
EVP, North America Commercial
Sold, plan not stated
15,085
$163.60K
50.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
1 Mar 2021
EVP, North America Commercial
Sold, plan not stated
73,127
$798.02K
70.9%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
9 Feb 2021
EVP, North America Commercial
Sold, plan not stated
20,694
$262.70K
20.9%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
17 Mar 2020
EVP, North America Commercial
Sold, plan not stated
470
$3.37K
3.1%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
3 Mar 2020
EVP, North America Commercial
Sold, plan not stated
463
$5.26K
3.2%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
10 Feb 2020
EVP, North America Commercial
Sold, plan not stated
4,799
$58.88K
26.3%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
18 Sep 2019
EVP, North America Commercial
Sold, plan not stated
494
$3.87K
18.8%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
18 Mar 2019
EVP, North America Commercial
Sold, plan not stated
1,179
$19.60K
45.9%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
12 Mar 2019
EVP, North America Commercial
Sold, plan not stated
738
$11.57K
34.7%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
4 Mar 2019
EVP, North America Commercial
Sold, plan not stated
1,166
$19.69K
45.6%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
18 Sep 2018
EVP, North America Commercial
Sold, plan not stated
1,241
$29.42K
47.2%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
19 Mar 2018
EVP, North America Commercial
Sold, plan not stated
1,179
$21.08K
45.9%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
12 Mar 2018
EVP, North America Commercial
Sold, plan not stated
738
$14.38K
34.7%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
5 Mar 2018
EVP, North America Commercial
Sold, plan not stated
705
$13.66K
33.7%
17 decisions on file.